NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
- Baxter’s Theranova Dialyzer Debuts Posted 11-12-2020
- CVS Health Announces New CEO Posted 11-12-2020
- Redsense Rocks Posted 10-12-2020
- Medtronic to Acquire Avenu Medical—and Ellipsys Endovascular System Posted 10-12-2020